3 completed, 2 terminated, 1 recruiting. 4 Phase 2, 3 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 2 |
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Fibrinolysin: new trials by email Literature Review of Fibrinolysin trials Research Report on Fibrinolysin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SWIFT - SWIss Factor XIII Trial in PPH Fibrogammin - Postpartum Hemorrhage, Coagulation Disorder | Phase 4 | Recruiting | Christian Haslinger | 988 | 2024-07-09 | 2026-04-27 |
| A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion Plasmin, Plasminogen Activator, Placebo - Acute Peripheral Arterial Occlusion | Phase 2 | Completed | Grifols Therapeutics LLC | 174 | 2010-12-01 | 2017-01-16 |
| A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients Plasmin (Human) - Acute Ischemic Stroke | Phase 1 / Phase 2 | Completed | Grifols Therapeutics LLC | 40 | 2009-11-01 | 2015-10-21 |
| A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft Occlusion Plasmin (Human) 25 mg, Plasmin (Human) 50 mg, Plasmin (Human) 75 mg - Arterial Occlusive Diseases | Phase 1 | Completed | Grifols Therapeutics LLC | 83 | 2007-03-01 | 2016-10-31 |
| A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD) Plasmin - Vitreoretinal Traction Syndrome | Phase 1 / Phase 2 | Terminated | Bausch & Lomb Incorporated | 4 | 2006-09-01 | 2019-06-21 |
| Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment Plasmin, Vehicle - Vitreoretinal Traction Syndrome | Phase 2 | Terminated | Bausch & Lomb Incorporated | 29 | 2006-04-01 | 2019-06-21 |
Thrombosis (2) · Arterial Occlusive Diseases (1) · Hemorrhage (1) · Hemostatic Disorders (1) · Ischemia (1) · Ischemic Stroke (1) · Peripheral Vascular Diseases (1) · Postpartum Hemorrhage (1) · Stroke (1)
Grifols Therapeutics LLC (3) · Bausch & Lomb Incorporated (2) · Christian Haslinger (1)
United States (4) · Serbia (2) · Slovakia (2) · Spain (2) · Australia (1) · Austria (1) · Belgium (1) · Bulgaria (1) · Czechia (1) · France (1) · Germany (1) · India (1) · Peru (1) · Poland (1) · Romania (1)
Anthony J Comerota, MD (1) · Beatrice Mosimann, Prof. Dr. (1) · Christian Haslinger, Prof. Dr. (1) · Jarmila Zdanowicz, MD (1) · Jeffrey Saver, MD (1) · Kecia Courtney (1) · Leila Sultan-Beyer, MD (1) · Michael Winter, MD (1) · Peter Mitchell, MD (1) · Sara de Oliveira, MD (1) · Tina Fischer, MD (1)